Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Rosner

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Deutsches Arzteblatt International|February 23, 2023
False-Positive Blood Group A in the Bedside Pre-Transfusion Compatibility TestAndrea Rosner, Steffen Jahn, Katja Preiß
Pathology Oncology Research : POR|June 1, 2013
Plasma levels of phospholipase A2-IIA in patients with different types of malignancies: prognosis and association with inflammatory and coagulation biomarkersMario Menschikowski, Albert Hagelgans, Ulrich Schuler, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 16, 2006
Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude miceVerena Quennet, Ala Yaromina, Daniel Zips, et al.
Toxicologic Pathology|June 24, 2004
Validation: the new challenge for pathologyRobert D Cardiff, Andrea Rosner, Michael A Hogarth, et al.
Cancer Research|July 5, 2005
Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesisMarganit Farago, Isabel Dominguez, Esther Landesman-Bollag, et al.
The American Journal of Pathology|December 6, 2002
Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertionGouri Chatterjee, Andrea Rosner, Yi Han, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2007
Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiationAla Yaromina, Marie Krause, Howard Thames, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 19, 2005
Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?Ala Yaromina, Tobias Hölscher, Wolfgang Eicheler, et al.
International Journal of Oncology|September 6, 2005
Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpressionAnthony Nguyen, Andrea Rosner, Tatjana Milovanovic, et al.
The American Journal of Pathology|September 6, 2002
Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumorsAndrea Rosner, Keiko Miyoshi, Esther Landesman-Bollag, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Deutsches Arzteblatt International|February 23, 2023
False-Positive Blood Group A in the Bedside Pre-Transfusion Compatibility TestAndrea Rosner, Steffen Jahn, Katja Preiß
Pathology Oncology Research : POR|June 1, 2013
Plasma levels of phospholipase A2-IIA in patients with different types of malignancies: prognosis and association with inflammatory and coagulation biomarkersMario Menschikowski, Albert Hagelgans, Ulrich Schuler, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 16, 2006
Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude miceVerena Quennet, Ala Yaromina, Daniel Zips, et al.
Toxicologic Pathology|June 24, 2004
Validation: the new challenge for pathologyRobert D Cardiff, Andrea Rosner, Michael A Hogarth, et al.
Cancer Research|July 5, 2005
Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesisMarganit Farago, Isabel Dominguez, Esther Landesman-Bollag, et al.
The American Journal of Pathology|December 6, 2002
Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertionGouri Chatterjee, Andrea Rosner, Yi Han, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2007
Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiationAla Yaromina, Marie Krause, Howard Thames, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 19, 2005
Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?Ala Yaromina, Tobias Hölscher, Wolfgang Eicheler, et al.
International Journal of Oncology|September 6, 2005
Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpressionAnthony Nguyen, Andrea Rosner, Tatjana Milovanovic, et al.
The American Journal of Pathology|September 6, 2002
Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumorsAndrea Rosner, Keiko Miyoshi, Esther Landesman-Bollag, et al.
Pageof 2